Clinical Trials
3 trialsNCT02954874 2026-06-03
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06297265 2025-12-18
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
University of Southern California
Phase NA Recruiting
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed